WinProbe Corporation is in the process of obtaining FDA 510K approval for the UltraVision and ISO13485 Quality Standard certification and CE for the company. These compliance issues will be completed in the first quarter of 2010 and clinical sales will commence shortly thereafter.

The Clinical System will have preset protocols optimized by WinProbe for image production of:

• B-Mode Gray Scale morphological imaging
• M-Mode Gray Scale movement imaging
• Color Doppler Imaging
• Elastography Strain Imaging.

The first product line has been developed specifically for the diagnosis of breast cancer and small parts.

Product is now in development for the diagnosis and ageing of Deep Vein Thrombosis.